Literature DB >> 18688046

Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1.

Guijun Yan1, Bei You, Shao-Ping Chen, James K Liao, Jianxin Sun.   

Abstract

Endothelium-derived nitric oxide (NO) is an important regulator of vascular function. NO is produced by endothelial NO synthase (eNOS), whose expression is downregulated by tumor necrosis factor (TNF)-alpha at the posttranscriptional level. To elucidate the molecular basis of TNF-alpha-mediated eNOS mRNA instability, eNOS 3' untranslated region (3'-UTR) binding proteins were purified by RNA affinity chromatography from cytosolic fractions of TNF-alpha-stimulated human umbilical vein endothelial cells (HUVECs). The formation of 3'-UTR ribonucleoprotein complexes, with molecular weight of 52 and 57 kDa, was increased by TNF-alpha. Matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis of the 52-kDa protein identified 3 peptides that comprise the peptide sequence of translation elongation factor 1-alpha 1 (eEF1A1). In HUVECs, TNF-alpha rapidly increased eEF1A1 expression, which is maximal after 1 hour and persists for up to 48 hours. RNA gel mobility-shift and UV cross-linking assays indicated that recombinant glutathione S-transferase-eEF1A1 fusion protein specifically binds to a UC-rich sequence in the 3'-UTR of eNOS mRNA. In addition, the domain III of eEF1A1 mediates the binding of eNOS 3'-UTR in eEF1A1. Overexpression of eEF1A1 markedly attenuated the expression of eNOS and luciferase gene fused with eNOS 3'-UTR in both COS-7 cells and bovine aortic endothelial cells (BAECs). Furthermore, adenovirus-mediated overexpression of eEF1A1 increased eNOS mRNA instability, whereas knockdown of eEF1A1 substantially attenuated TNF-alpha-induced destabilization of eNOS mRNA and downregulation of eNOS expression in HUVECs. These results indicate that eEF1A1 is a novel eNOS 3'-UTR binding protein that plays a critical role in mediating TNF-alpha-induced decrease in eNOS mRNA stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688046      PMCID: PMC2753820          DOI: 10.1161/CIRCRESAHA.108.173963

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  45 in total

1.  The cytoskeleton in mRNA localization and cell differentiation.

Authors:  K Nasmyth; R P Jansen
Journal:  Curr Opin Cell Biol       Date:  1997-06       Impact factor: 8.382

Review 2.  Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression.

Authors:  Charles D Searles
Journal:  Am J Physiol Cell Physiol       Date:  2006-05-31       Impact factor: 4.249

3.  Evidence that an endothelial cytosolic protein binds to the 3'-untranslated region of endothelial nitric oxide synthase mRNA.

Authors:  L Sánchez de Miguel; J Alonso; F González-Fernández; J de la Osada; M Montón; J A Rodríguez-Feo; J I Guerra; M M Arriero; L Rico; S Casado; A López-Farré
Journal:  J Vasc Res       Date:  1999 May-Jun       Impact factor: 1.934

4.  Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha.

Authors:  L Agnoletti; S Curello; T Bachetti; F Malacarne; G Gaia; L Comini; M Volterrani; P Bonetti; G Parrinello; M Cadei; P G Grigolato; R Ferrari
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Elongation factor-1 alpha is a novel substrate of rho-associated kinase.

Authors:  T Izawa; Y Fukata; T Kimura; A Iwamatsu; K Dohi; K Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

6.  Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.

Authors:  Andrea Picchi; Xue Gao; Souad Belmadani; Barry J Potter; Marta Focardi; William M Chilian; Cuihua Zhang
Journal:  Circ Res       Date:  2006-06-01       Impact factor: 17.367

7.  Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system.

Authors:  D Sumi; T Hayashi; M Jayachandran; A Iguchi
Journal:  Life Sci       Date:  2001-08-24       Impact factor: 5.037

8.  Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro.

Authors:  Simona Cardaropoli; Francesca Silvagno; Emanuella Morra; Gian Piero Pescarmona; Tullia Todros
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

9.  Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Authors:  Masao Takemoto; Jianxin Sun; Junko Hiroki; Hiroaki Shimokawa; James K Liao
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

10.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Authors:  M Endres; U Laufs; Z Huang; T Nakamura; P Huang; M A Moskowitz; J K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  52 in total

1.  Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers.

Authors:  Sasanka S Chukkapalli; Mercedes F Rivera-Kweh; Irina M Velsko; Hao Chen; Donghang Zheng; Indraneel Bhattacharyya; Pandu R Gangula; Alexandra R Lucas; Lakshmyya Kesavalu
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

2.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

3.  Antiobesogenic role of endothelial nitric oxide synthase.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Vitam Horm       Date:  2014       Impact factor: 3.421

4.  MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.

Authors:  Paul R Clark; Todd J Jensen; Martin S Kluger; Maurice Morelock; Adedayo Hanidu; Zhenhao Qi; Revati J Tatake; Jordan S Pober
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

5.  Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice.

Authors:  Yukio Hiroi; Kensuke Noma; Hyung-Hwan Kim; Nikola Sladojevic; Corey E Tabit; Yuxin Li; Guray Soydan; Salvatore Salomone; Michael A Moskowitz; James K Liao
Journal:  Circ J       Date:  2018-01-19       Impact factor: 2.993

6.  Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs.

Authors:  J J David Ho; G Brett Robb; Sharon C Tai; Paul J Turgeon; Imtiaz A Mawji; H S Jeffrey Man; Philip A Marsden
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

Review 7.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

8.  Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis.

Authors:  Gin C Chuang; Zhen Yang; David G Westbrook; Melissa Pompilius; Carol A Ballinger; C Roger White; David M Krzywanski; Edward M Postlethwait; Scott W Ballinger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-24       Impact factor: 5.464

Review 9.  Regulation of obesity and insulin resistance by nitric oxide.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.